Disease The intractable diseases designated by MHLW, Japan
Diseases : 338 - Clinical trials : 34,520 / Drugs : 19,957 - ( DrugBank : 2,195 ) / Drug target genes : 613 - Drug target pathways : 297
ID | Disease name [Group] | Clinical trial Phase 1 / 2 / 3 / 4 | Drug [ DrugBank ] | Target gene Target pathway | Domestic patients Med expenses recipients (FY2022) |
---|---|---|---|---|---|
34 | Neurofibromatosis [Skin] 💬 "Neurofibromatosis type I", "NF1", "von Recklinghausen disease", "Neurofibromatosis type II", "NF2" | 133 133 trials | 54 / 85 / 15 / 8 💬 | 186 186 drugs [ 67 67 drugs ] | 79 79 genes 190 pathways | 4056 4,056 patientsAge distribution💬 |
35 | Pemphigus [Skin] 💬 "Pemphigus vulgaris", "Pemphigus foliaceus", "Pemphigus erythematosus", "Herpetiform pemphigus", "Drug-induced pemphigus", "DIP", "Paraneoplastic pemphigus", "PNP" | 99 99 trials | 44 / 36 / 49 / 7 💬 | 124 124 drugs [ 36 36 drugs ] | 23 23 genes 169 pathways | 3176 3,176 patientsAge distribution💬 |
36 | Epidermolysis bullosa [Skin] 💬 "Epidermolysis bullosa simplex", "EBS", "Junctional epidermolysis bullosa", "JEB", "Junctional epidermolysis bullosa type Herlitz", "JEB-H", "Junctional epidermolysis bullosa type non-Herlitz", "JEB-nH", "Dominant dystrophic epidermolysis bullosa", "DDEB", "Dystrophic epidermolysis bullosa", "DEB", "Epidermolysis bullosa dystrophica", "Recessive dystrophic epidermolysis bullosa", "RDEB", "Kindler syndrome" | 163 163 trials | 117 / 99 / 53 / 16 💬 | 185 185 drugs [ 46 46 drugs ] | 50 50 genes 125 pathways | 291 291 patientsAge distribution💬 |
37 | Generalised pustular psoriasis [Skin] 💬 "Pustular psoriasis", "Acute generalised pustular psoriasis, von Zumbusch type", "Herpetic impetigo", "Generalization of acrodermatitis continua", "Generalization of dermatitis continua of the extremities", "Infantile generalized pustular psoriasis", "Pediatric generalized pustular psoriasis" | 79 79 trials | 27 / 30 / 39 / 8 💬 | 57 57 drugs [ 21 21 drugs ] | 20 20 genes 102 pathways | 2132 2,132 patientsAge distribution💬 |
38 | Stevens-Johnson syndrome [Skin] 💬 "SJS", "Mucocutaneous ocular syndrome" | 17 17 trials | 11 / 11 / 4 / 2 💬 | 29 29 drugs [ 9 9 drugs ] | 15 15 genes 101 pathways | 171 171 patientsAge distribution💬 |
39 | Toxic epidermal necrolysis [Skin] 💬 "Toxic epidermal necrosis", "TEN" | 13 13 trials | 5 / 8 / 2 / 1 💬 | 19 19 drugs [ 8 8 drugs ] | 11 11 genes 103 pathways | 71 71 patientsAge distribution💬 |
159 | Xeroderma pigmentosum [Skin] 💬 "XP", "XP-A", "XP-B", "XP-C", "XP-D", "XP-E", "XP-F", "XP-G", "XP-V" | 11 11 trials | 1 / 8 / 1 / 0 💬 | 17 17 drugs [ 5 5 drugs ] | 5 5 genes 15 pathways | 82 82 patientsAge distribution💬 |
160 | Congenital ichthyosis [Skin] 💬 "Keratinopathic ichthyosis", "Epidermolytic ichthyosis", "Superficial epidermolytic ichthyosis", "Harlequin ichthyosis", "Autosomal recessive congenital ichthyosis", "Congenital Ichthyosiform Erythroderma", "Foliate ichthyosis", "Ichthyosis syndrome", "Netherton syndrome", "Sjogren-Larsson syndrome", "Sjögren-Larsson syndrome", "Keratitis-ichtyosis-deafness syndrome", "Dorfman-Chanarin syndrome", "Neutral lipid storage disease", "NLSD", "Multiple sulfatase deficiency", "Austin disease", "Recessive X-linked ichthyosis", "RXLI", "X-linked recessive ichthyosis", "Ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature", "IBID", "Trichothiodystrophy", "Follicular ichthyosis", "Congenital hemidysplasia, ichthyosiform erythroderma or nevus, and limb defects syndrome", "CHILD syndrome", "Conradi-Hunermann-Happle syndrome", "Conradi-Hünermann-Happle syndrome", "CHHS" | 42 42 trials | 25 / 21 / 11 / 5 💬 | 71 71 drugs [ 21 21 drugs ] | 18 18 genes 112 pathways | 100 100 patientsAge distribution💬 |
161 | Familial benign chronic pemphigus [Skin] 💬 "Benign familial pemphigus", "Hailey-Hailey disease" | 5 5 trials | 2 / 2 / 0 / 0 💬 | 9 9 drugs [ 4 4 drugs ] | 2 2 genes 24 pathways | 63 63 patientsAge distribution💬 |
162 | Pemphigoid [Skin] 💬 "Bullous pemphigoid", "BP", "Epidermolysis bullosa acquisita", "Mucous membrane pemphigoid", "MMP", "Cicatricial pemphigoid" | 90 90 trials | 24 / 43 / 30 / 8 💬 | 122 122 drugs [ 47 47 drugs ] | 34 34 genes 144 pathways | 3850 3,850 patientsAge distribution💬 |
163 | Idiopathic pure sudomotor failure [Skin] 💬 "Idiopathic acquired systemic anhidrosis", "Acquired idiopathic generalized anhidrosis", "AIGA", "Idiopathic segmental anhidrosis", "IPSF", "Sweat gland failure" | 0 - | 0 - | 0 - | 636 636 patientsAge distribution💬 |
166 | Pseudoxanthoma elasticum [Skin] 💬 "PXE" | 16 16 trials | 3 / 13 / 2 / 1 💬 | 27 27 drugs [ 5 5 drugs ] | 5 5 genes 28 pathways | 132 132 patientsAge distribution💬 |